Vimarsana
Biggest News Aggregation in the World

Page 12 - Tim Pearson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tim Pearson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tim Pearson Today - Breaking & Trending Today

Migrants forced out of Manhattan shelter deemed unsafe by FDNY, leaving some fearful they could wind up on the streets - Vimarsana News

Migrants forced out of Manhattan shelter deemed unsafe by FDNY, leaving some fearful they could wind up on the streets

NEW YORK — Scores of migrants were forced out Monday from an emergency shelter in Manhattan that was deemed unsafe by the FDNY, leaving them to return to the asylum seeker arrival center for a new place and fearful they could end up sleeping on the streets. Evictions were ordered at the shelter operating out of an old Touro College building on W. 31st St. near Eighth Ave. after the FDNY found ...

Source: yahoo.com
Adams aide gets into scuffle with security guards at NYC migrant center - Vimarsana News

Adams aide gets into scuffle with security guards at NYC migrant center

Tim Pearson, one of Mayor Eric Adams’ prominent aides, got into a tussle with security guards at a Manhattan migrant assistance center on Tuesday night, according to police sources.

Source: nypost.com
Newlin celebrates 10 years with Raybestos Powertrain - Vimarsana News

Newlin celebrates 10 years with Raybestos Powertrain

Mitchell Newlin celebrated 10 years of service with Raybestos Powertrain on Wednesday. Newlin started with Raybestos Powertrain in 2013 as an operator. He has since held positions in inventory …

Apple @ Work Podcast: We've got 81 problems, but compliance isn't one of them - Vimarsana News

Apple @ Work Podcast: We've got 81 problems, but compliance isn't one of them

In this episode of Apple @ Work, I talk with Ben Greiner from Addigy and Tim Pearson from Creative Techs about the challenges around compliance in the Apple enterprise world.

FDA Approves IND for CT7439, a Novel CDK12/13 Inhibitor to Treat Multiple Types of Advanced Solid Tumors - Vimarsana News

FDA Approves IND for CT7439, a Novel CDK12/13 Inhibitor to Treat Multiple Types of Advanced Solid Tumors

The CDK12/13 inhibitor will be tested for efficacy and safety in patients with advanced solid tumors, such as breast, ovarian, and Ewing Sarcoma.